Take Solutions (NSE:TAKE) EBIT : ₹-60.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Take Solutions EBIT?

Take Solutions's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was ₹3.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-60.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Take Solutions's annualized ROC % for the quarter that ended in Dec. 2023 was -2.95%. Take Solutions's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Take Solutions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1.83%.

Take Solutions EBIT Historical Data

The historical data trend for Take Solutions's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions EBIT Chart

Take Solutions Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

2,330.31

192.85

-4,093.33

-509.69

-381.77

Take Solutions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															-69.39	-26.16	-35.51	-2.28	3.63

Competitive Comparison of Take Solutions's EBIT

For the Biotechnology subindustry, Take Solutions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Take Solutions's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Take Solutions's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Take Solutions's EV-to-EBIT falls into.

Take Solutions EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-60.3 Mil.

Take Solutions (NSE:TAKE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Take Solutions's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-28.88 * ( 1 - -123.9% )	/	( (2193.57	+	0)	/ 1 )
=	-64.66232	/	2193.57
=	-2.95 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2136.62	-	189.46	-	( 100.38	-	max(0, 1010.62	-	764.21	+	100.38	))
=	2193.57

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Take Solutions's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	14.52	/	( ( (322.87 + max(-252.49, 0))	+	(0 + max(0, 0)) )	/	1 )
=	14.52	/	( ( 322.87	+	0 )	/	1 )
=	14.52	/	322.87
=	4.50 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(285.17	+	9.15	+	129.59)	-	(189.46	+	0	+	486.94)
=	-252.49

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Take Solutions's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-60.32	/	3299.118
	=	-1.83 %

Take Solutions EBIT Related Terms

Thank you for viewing the detailed overview of Take Solutions's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Take Solutions (NSE:TAKE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (NSE:TAKE) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

532890:India

Address

No. 27, Tank Bund Road, Nungambakkam, Chennai, TN, IND, 600 034

Website

https://www.takesolutions.com

Take Solutions Ltd is a technology-driven Clinical Research Organization in India. The company's operating segment includes Life Sciences and generates revenue from the Life Sciences segment. The company serves large and small biopharmaceutical companies as well as generics manufacturers.

Take Solutions (NSE:TAKE) Headlines

No Headlines